Original
Consensus statement on the use of biosimilar drugs in immune-mediated diseases in Spain
Documento de consenso sobre los medicamentos biosimilares en enfermedades inmunomediadas en España
a Servicio de Farmacia, Hospital Universitario y Politécnico La Fe, Valencia, España
b Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, España
c Unidad de Gestión Clínica de Aparato Digestivo, Hospital Universitario Virgen de la Victoria, Málaga, España
d Servicio de Reumatología, Hospital Universitari Arnau de Vilanova, Lleida, España
Read
2196
Timeswas read the article
1158
Total PDF
1038
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 10 | 19 | 81 | 100 |
| 2025 9 | 0 | 149 | 149 |
| 2025 8 | 0 | 94 | 94 |
| 2025 7 | 0 | 77 | 77 |
| 2025 6 | 0 | 60 | 60 |
| 2025 5 | 96 | 63 | 159 |
| 2025 4 | 71 | 55 | 126 |
| 2025 3 | 85 | 37 | 122 |
| 2025 2 | 75 | 46 | 121 |
| 2025 1 | 63 | 65 | 128 |
| 2024 12 | 48 | 48 | 96 |
| 2024 11 | 58 | 95 | 153 |
| 2024 10 | 49 | 50 | 99 |
| 2024 9 | 64 | 51 | 115 |
| 2024 8 | 65 | 40 | 105 |
| 2024 7 | 77 | 43 | 120 |
| 2024 6 | 69 | 34 | 103 |
| 2024 5 | 68 | 35 | 103 |
| 2024 4 | 108 | 21 | 129 |
| 2024 3 | 7 | 8 | 15 |
| 2023 12 | 12 | 4 | 16 |
| 2023 11 | 3 | 2 | 5 |
| 2023 10 | 1 | 0 | 1 |
Show all
